Table 2 Clinical characteristics of patients with multidrug-resistant tuberculosis in association with pyrazinamide susceptibility
Characteristics | All N = 30 | PZA (S) N = 15 | PZA(R) N = 15 | p-value |
|---|---|---|---|---|
Mean age in years ±SD | 33 ± 10 | 34 ± 8 | 31 ± 12 | P = 0.44 |
Gender, Female (%N) | 7 (23) | 5 (33) | 2 (13) | P = 0.39 |
Smoking (%N) | 6 (20) | 3 (20) | 3 (20) | P > 0.99 |
HIV positive (%N) | 6 (20) | 5 (33) | 1 (7) | P = 0.17 |
On ART (%HIV positive) | 5 (90) | 4 (80) | 1 (100) | N/A |
Prior TB treatment (%N) | 25 (83) | 13 (87) | 12 (80) | P = 0.63 |
Cavity on chest x-ray (%N) | 8 (26.7) | 5 (33.3) | 3 (20) | P = 0.68 |